Get the newest information about «Cancer»

How often would you like to receive alerts from fhi.no? (This affects all your alerts)

As soon as new content is published
Daily
Weekly

You will only receive an alert if new information was published since you received one.

[Missing text '/shared/subscription/emailadress' for 'English']

The email address you register will only be used to send you these alerts. You can cancel and delete your email address at any time by following the link in the alerts you receive.
Read more about the privacy policy for fhi.no

You have subscribed to alerts about:

Cancer

Cancer

Many environmental factors can influence cancer incidence. Genes also play a role. However, the causes of many types of cancer are still unknown.

Les på norsk

From NCD report

Indicators for Non-Communicable Diseases (NCD)

Cancer incidence (Indicator 2)

The indicator describes the following: cancer incidence, by type of cancer, per 100 000 person years.

Updated 02.12.2019

Indicators for Non-Communicable Diseases (NCD)

Palliative cancer care (Indicator 20)

The indicator describes the following: Access to palliative care assessed by morphine-equivalent consumption of strong opioid analgesics (in grams of morphine) per death from cancer.

Updated 07.01.2020

Reports

Mapping review

Effectiveness of treatment for pancreatic cancer

We were asked to find and summarize key findings from systematic reviews about the effectiveness of active observation treatment compared to surgery for patients with pancreatic cancer.

Published 11.05.2020

Systematic review

Treatment options for metastatic prostate cancer

We aimed to summarise findings about the effectiveness of androgen suppression therapy, chemotherapy, radiation and radioactive treatment in addition to standard care for metastatic prostate cancer.

Published 06.02.2020

Mapping review

Effectiveness of treatment for localized prostate cancer

The Centre for shared decision making commissioned the Norwegian Institute of Public Health to summarize findings about the effectiveness of relevant treatment for localized prostate cancer.

Published 29.08.2019

Health technology assessment

Prosigna Gene Signature to Assess Expected Benefit from Chemotherapy in Breast Cancer

We have considered a molecular profiling panel, Prosigna, which is meant to improve the assessment of recurrence risk among women who have undergone surgical treatment for breast cancer.

Published 16.08.2019

Mapping review

Effectiveness of mastectomy for women with breast cancer: evidence base for a shared decision making tool

We were commissioned to identify and summarize key findings from systematic reviews about the effects of mastectomy for women with small breast cancer tumour.

Published 23.05.2018

Health technology assessment

177Lutetium-based peptide receptor radionuclide therapy for treating neuroendocrine tumours: a health technology assessment

The Commission Forum representing the four National Regional Health Authorities (RHA) in Norway asked the Norwegian Institute of Public Health to conduct a full HTA of 177Lu-PRRT.

Published 09.04.2018

Health technology assessment

Diagnostic accuracy, clinical effectiveness and budget impact of screening BRCA1/2 mutation carriers by MRI. A health technology assessment

This is a HTA of the diagnostic accuracy, clinical effectiveness and budget impact of breast cancer screening using MRI in combination with mammography, for women with BRCA1/2 genetic mutations.

Published 23.03.2018

Health technology assessment

Digital Breast Tomosynthesis with Hologic 3D mammography Selenia Dimensions System for use in breast cancer screening

We were to perform a single technology assessment (STA) regarding “Three dimensional digital breast tomosynthesis in screening for breast cancer”.

Published 04.09.2017

Systematic review

The effectiveness of physical exercise for people with cancer

We have summarised the results from five systematic reviews, on the effects of exercise for cancer patients during and after cancer treatment, including a total of 119 randomised clinical trials.

Published 16.12.2016

Research findings

Nordic twin study highlights familial cancer risk
As many large breast tumours detected without mammography
Already reached target of 25 per cent fewer premature deaths

Projects

Treatments for relapsing, refractory multiple myeloma: A health technology assessment
08.01.21
Tests for detection of ROS1 gene alterations in patients with non-small cell lung cancer - Protocol for a rapid review
11.12.20
Childhood cancer and prenatal environmental exposures
18.03.20